{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:13:20Z","timestamp":1791184400518,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.regpep.2007.02.009","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T17:46:45Z","timestamp":1172857605000},"page":"39-46","source":"Crossref","is-referenced-by-count":37,"title":["Long-term serotonin effects in the rat are prevented by terguride"],"prefix":"10.1016","volume":"143","author":[{"given":"\u00d8yvind","family":"Hauso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn I.","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Loennechen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid K.","family":"Stunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivar","family":"Nordrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge L.","family":"Waldum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2007.02.009_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.regpep.2007.02.009_bib2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1073\/pnas.83.3.674","article-title":"Stimulation of aortic smooth muscle cell mitogenesis by serotonin","volume":"83","author":"Nemecek","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2007.02.009_bib3","doi-asserted-by":"crossref","first-page":"28961","DOI":"10.1074\/jbc.M101824200","article-title":"Expression of serotonin receptors in bone","volume":"276","author":"Westbroek","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2007.02.009_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jcb.20734","article-title":"Serotonin and fluoxetine modulate bone cell function in vitro","volume":"98","author":"Gustafsson","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.regpep.2007.02.009_bib5","first-page":"F431","article-title":"Studies of the mitogenic effect of serotonin in rat renal mesangial cells","volume":"257","author":"Takuwa","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.regpep.2007.02.009_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/335254a0","article-title":"Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a Gi-protein","volume":"335","author":"Seuwen","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.regpep.2007.02.009_bib7","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/01.CIR.90.4.1919","article-title":"Mitogenic effect of serotonin on vascular endothelial cells","volume":"90","author":"Pakala","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2007.02.009_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.1123842","article-title":"Platelet-derived serotonin mediates liver regeneration","volume":"312","author":"Lesurtel","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.regpep.2007.02.009_bib9","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/01.CIR.0000159356.42064.48","article-title":"Long-term serotonin administration induces heart valve disease in rats","volume":"111","author":"Gustafsson","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2007.02.009_bib10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine","volume":"57","author":"Fitzgerald","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.regpep.2007.02.009_bib11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jcp.10287","article-title":"Functional activity of serotoninergic and melatoninergic systems expressed in the skin","volume":"196","author":"Slominski","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.regpep.2007.02.009_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine\u2013phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.regpep.2007.02.009_bib13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0140-6736(04)15945-X","article-title":"Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease","volume":"363","author":"Van Camp","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.regpep.2007.02.009_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00045415-200211000-00005","article-title":"Fibrotic valvular heart disease subsequent to bromocriptine treatment","volume":"10","author":"Serratrice","year":"2002","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.regpep.2007.02.009_bib15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mds.20201","article-title":"Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists","volume":"19","author":"Horvath","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.regpep.2007.02.009_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ejphar.2005.03.010","article-title":"Agonism at 5-HT2B receptors is not a class effect of the ergolines","volume":"513","author":"J\u00e4hnichen","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2007.02.009_bib17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/jpet.102.039883","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.regpep.2007.02.009_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.CIR.89.1.345","article-title":"Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat","volume":"89","author":"Litwin","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2007.02.009_bib19","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1161\/hc1102.105258","article-title":"Effects of cariporide and losartan on hypertrophy, calcium transients, contractility, and gene expression in congestive heart failure","volume":"105","author":"Loennechen","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.regpep.2007.02.009_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ndt\/16.3.500","article-title":"Cyclosporin A affects extracellular matrix synthesis and degradation by mouse MC3T3-E1 osteoblasts in vitro","volume":"16","author":"Fornoni","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.regpep.2007.02.009_bib21","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/mds.20328","article-title":"Dopaminagonists and fibrotic valvular heart disease: further considerations","volume":"19","author":"Rascol","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.regpep.2007.02.009_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1440-1843.2006.00778.x","article-title":"Pulmonary arterial hypertension: new insights and new hope","volume":"11","author":"Martin","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.regpep.2007.02.009_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1440-1681.2004.04095.x","article-title":"Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats","volume":"31","author":"Polakowski","year":"2004","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.regpep.2007.02.009_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00053427","article-title":"Carcinoid syndrome and serotonin: therapeutic effects of ketanserin","volume":"4","author":"Robertson","year":"1990","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.regpep.2007.02.009_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1517\/13543784.15.3.257","article-title":"The potential use of selective 5-HT2C agonists in treating obesity","volume":"15","author":"Smith","year":"2006","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.regpep.2007.02.009_bib26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/mi.5.5.8","article-title":"Serotonin 5-ht2c receptor agonists: potential for the treatment of obesity","volume":"5","author":"Miller","year":"2005","journal-title":"Mol Interv"},{"key":"10.1016\/j.regpep.2007.02.009_bib27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1096\/fj.01-0952fje","article-title":"Serotoninergic and melatoninergic systems are fully expressed in human skin","volume":"16","author":"Slominski","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.regpep.2007.02.009_bib28","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1046\/j.1523-1747.2002.00156.x","article-title":"Serotoninergic system in hamster skin","volume":"119","author":"Slominski","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.regpep.2007.02.009_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0925-4439(03)00124-8","article-title":"Tryptophan hydroxylase expression in human skin cells","volume":"1639","author":"Slominski","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.regpep.2007.02.009_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00403-002-0350-y","article-title":"Expression of serotonin receptors in allergic contact eczematous human skin","volume":"294","author":"Lundeberg","year":"2002","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.regpep.2007.02.009_bib31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1096\/fj.04-2079rev","article-title":"The cutaneous serotoninergic\/melatoninergic system: securing a place under the sun","volume":"19","author":"Slominski","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.regpep.2007.02.009_bib32","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-4632.2004.02196.x","article-title":"Immunohistochemical study of serotonin in lesions of chronic eczema","volume":"43","author":"Huang","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.regpep.2007.02.009_bib33","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-4632.2004.02195.x","article-title":"Immunohistochemical study of serotonin in lesions of psoriasis","volume":"43","author":"Huang","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.regpep.2007.02.009_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/03009740410007078","article-title":"Treatment of systemic sclerosis with the 5-HT3 receptor antagonist tropisetron","volume":"119","author":"Stratz","year":"2004","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1016\/j.regpep.2007.02.009_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1440-1843.2000.00222.x","article-title":"Suppressive effect of saprogrelate hydrochloride on Raynaud's phenomenon and respiratory failure in patients with systemic sclerosis","volume":"5","author":"Kato","year":"2000","journal-title":"Respirology"},{"key":"10.1016\/j.regpep.2007.02.009_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.2004.06273.x","article-title":"Cutaneous manifestations of the malignant carcinoid syndrome","volume":"152","author":"Bell","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.regpep.2007.02.009_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0923-1811(97)00043-1","article-title":"The mast cell products histamine and serotonin stimulate and TNF-alpha inhibits the proliferation of murine epidermal keratinocytes in situ","volume":"16","author":"Maurer","year":"1997","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.regpep.2007.02.009_bib38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.0022-202X.2005.23873.x","article-title":"Dopamine D2-like receptor agonists accelerate barrier repair and inhibit the epidermal hyperplasia induced by barrier disruption","volume":"125","author":"Fuziwara","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.regpep.2007.02.009_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1124\/jpet.103.049239","article-title":"5-Hydroxytryptamine (5-HT)2 receptor involvement in acute 5-HT-evoked scratching but not in allergic pruritus induced by dinitrofluorobenzene in rats","volume":"306","author":"Nojima","year":"2003","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011507000547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011507000547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:57:37Z","timestamp":1736863057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011507000547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":39,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0167011507000547"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2007.02.009","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}